Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Graser

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Plos Computational Biology|February 4, 2025
Repeated games with partner choiceChristopher Graser, Takako Fujiwara-Greve, Julián García, et al.
Journal for Immunotherapy of Cancer|June 19, 2025
Response to: Correspondence on "Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab" by Gao <i>et al</i>Christopher Graser, Thomas O McDonald, Paul J Catalano, et al.
NPJ Digital Medicine|November 27, 2025
Shedding light on the dynamic interplay of positive and negative symptoms of psychosis with Behavioral TractographyAndrea Imparato, Natacha Reich, Clémence Feller, et al.
Cancer Discovery|April 2, 2026
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapiesMarie-Anne Goyette, Christopher Graser, Marco Seehawer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Plos Computational Biology|February 4, 2025
Repeated games with partner choiceChristopher Graser, Takako Fujiwara-Greve, Julián García, et al.
Journal for Immunotherapy of Cancer|June 19, 2025
Response to: Correspondence on "Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab" by Gao <i>et al</i>Christopher Graser, Thomas O McDonald, Paul J Catalano, et al.
NPJ Digital Medicine|November 27, 2025
Shedding light on the dynamic interplay of positive and negative symptoms of psychosis with Behavioral TractographyAndrea Imparato, Natacha Reich, Clémence Feller, et al.
Cancer Discovery|April 2, 2026
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapiesMarie-Anne Goyette, Christopher Graser, Marco Seehawer, et al.
Pageof 1